Equisetum arvense standardized dried extract hinders age-related osteosarcopenia

Age-associated osteosarcopenia is an unresolved syndrome characterized by the concomitant loss of bone (osteopenia) and skeletal muscle (sarcopenia) tissues increasing falls, immobility, morbidity, and mortality. Unbalanced resorption of bone in the remodeling process and excessive protein breakdown...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Biomedicine & pharmacotherapy 2024-05, Vol.174, p.116517-116517, Article 116517
Hauptverfasser: Salvadori, Laura, Paiella, Martina, Castiglioni, Beatrice, Belladonna, Maria Laura, Manenti, Tommaso, Ercolani, Catia, Cornioli, Luca, Clemente, Nausicaa, Scircoli, Andrea, Sardella, Roccaldo, Tensi, Leonardo, Astolfi, Andrea, Barreca, Maria Letizia, Chiappalupi, Sara, Gentili, Giulia, Bosetti, Michela, Sorci, Guglielmo, Filigheddu, Nicoletta, Riuzzi, Francesca
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Age-associated osteosarcopenia is an unresolved syndrome characterized by the concomitant loss of bone (osteopenia) and skeletal muscle (sarcopenia) tissues increasing falls, immobility, morbidity, and mortality. Unbalanced resorption of bone in the remodeling process and excessive protein breakdown, especially fast type II myosin heavy chain (MyHC-II) isoform and myofiber metabolic shift, are the leading causes of bone and muscle deterioration in the elderly, respectively. Equisetum arvense (EQ) is a plant traditionally recommended for many pathological conditions due to its anti-inflammatory properties. Thus, considering that a chronic low-grade inflammatory state predisposes to both osteoporosis and sarcopenia, we tested a standardized hydroalcoholic extract of EQ in in vitro models of muscle atrophy [C2C12 myotubes treated with proinflammatory cytokines (TNFα/IFNγ), excess glucocorticoids (dexamethasone), or the osteokine, receptor activator of nuclear factor kappa-B ligand (RANKL)] and osteoclastogenesis (RAW 264.7 cells treated with RANKL). We found that EQ counteracted myotube atrophy, blunting the activity of several pathways depending on the applied stimulus, and reduced osteoclast formation and activity. By in silico target fishing, IKKB-dependent nuclear factor kappa-B (NF-κB) inhibition emerges as a potential common mechanism underlying EQ′s anti-atrophic effects. Consumption of EQ (500 mg/kg/day) by pre-geriatric C57BL/6 mice for 3 months translated into: i) maintenance of muscle mass and performance; ii) restrained myofiber oxidative shift; iii) slowed down age-related modifications in osteoporotic bone, significantly preserving trabecular connectivity density; iv) reduced muscle- and spleen-related inflammation. EQ can preserve muscle functionality and bone remodeling during aging, potentially valuable as a natural treatment for osteosarcopenia. [Display omitted] •Equisetum arvense extract counteracts myotube atrophy by blunting several pathways depending on the applied stimulus.•By in silico target fishing, NF-κB emerges as a common mechanism underlying the Equisetum arvense ′s anti-atrophic effects.•Equisetum arvense preserves muscle mass and performance and restrains muscle and spleen inflammatory state in geriatric mice.•Equisetum arvense reduces osteoclastogenesis in vitro and slows down age-related modifications in osteoporotic mice.•Equisetum arvense appears as a promising source of active compounds useful in counteracting osteosarcop
ISSN:0753-3322
1950-6007
DOI:10.1016/j.biopha.2024.116517